Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Skin-restricted commensal colonization accelerates skin graft rejection
Yuk Man Lei, … , Yasmine Belkaid, Maria-Luisa Alegre
Yuk Man Lei, … , Yasmine Belkaid, Maria-Luisa Alegre
Published July 16, 2019
Citation Information: JCI Insight. 2019;4(15):e127569. https://doi.org/10.1172/jci.insight.127569.
View: Text | PDF
Research Article Immunology Transplantation

Skin-restricted commensal colonization accelerates skin graft rejection

  • Text
  • PDF
Abstract

Solid organ transplantation can treat end-stage organ failure, but the half-life of transplanted organs colonized with commensals is much shorter than that of sterile organs. Whether organ colonization plays a role in this shorter half-life is not known. We have previously shown that an intact whole-body microbiota can accelerate the kinetics of solid organ allograft rejection in untreated colonized mice, when compared with germ-free (GF) or with antibiotic-pretreated colonized mice, by enhancing the capacity of antigen-presenting cells (APCs) to activate graft-reactive T cells. However, the contribution of intestinal versus skin microbiota to these effects was unknown. Here, we demonstrate that colonizing the skin of GF mice with a single commensal, Staphylococcus epidermidis, while preventing intestinal colonization with oral vancomycin, was sufficient to accelerate skin graft rejection. Notably, unlike the mechanism by which whole-body microbiota accelerates skin graft rejection, cutaneous S. epidermidis did not enhance the priming of alloreactive T cells in the skin-draining lymph nodes. Rather, cutaneous S. epidermidis augmented the ability of skin APCs to drive the differentiation of alloreactive T cells. This study reveals that the extraintestinal donor microbiota can affect transplant outcome and may contribute to the shorter half-life of colonized organs.

Authors

Yuk Man Lei, Martin Sepulveda, Luqiu Chen, Ying Wang, Isabella Pirozzolo, Betty Theriault, Anita S. Chong, Yasmine Belkaid, Maria-Luisa Alegre

×

Figure 2

S. epidermidis skin colonization does not change the composition or costimulatory molecule expression of LN APCs relative to GF APCs.

Options: View larger image (or click on image) Download as PowerPoint

S. epidermidis skin colonization does not change the composition or cos...
APCs from the peripheral LNs of specific pathogen–free (SPF), GF, and 10-day-painted S. epidermidis–monocolonized GF mice were analyzed by flow cytometry. (A) Gating strategy for different dendritic cell (DC) populations and fold change relative to the average in the percentage of DC subsets observed in GF controls within each experiment. LC, Langerhans cell. (B) Fold change in mean fluorescence intensity (MFI) relative to that in GF mice for costimulatory molecules on CD11c+-gated cells. Data were normalized from 3 individual experiments with n = 2–5 per group. Data represent the mean ± SEM. Statistical analyses were performed using the Kruskal-Wallis test for multiple comparisons. *P < 0.05; **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts